[Retracted] Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure

Table 1

Comparison of clinical data between observation group and control group (n,  ± s, %).

Item	Control group (n = 50)	Observation group (n = 50)	χ^2/t value	-Value
Age (years)	73.54 ± 2.92	74.16 ± 2.94	1.058	0.293
Male	27 (54.00%)	30 (60.00%)	0.367	0.545
History of coronary heart disease	24 (48.00%)	28 (56.00%)	0.641	0.423
History of diabetes	12 (24.00%)	15 (30.00%)	0.457	0.499
History of hypertension	29 (58.00%)	31 (62.00%)	0.167	0.683
WBC (×10^9/L)	5.77 ± 1.16	6.38 ± 1.34	2.433	0.017
NEU (×10^9/L)	3.41 ± 0.93	4.88 ± 1.20	6.846	<0.001
LYM (×10^9/L)	1.95 ± 0.41	1.49 ± 0.28	6.551	<0.001
PLT (×10^9/L)	202.64 ± 42.72	187.97 ± 39.08	1.791	0.076
Blood glucose (mmol/L)	5.75 ± 1.23	6.20 ± 1.44	1.680	0.096
NLR	1.72 ± 0.16	3.50 ± 1.78	7.043	<0.001
NT-proBNP (pg/ml)	267.34 ± 37.61	3748.11 ± 413.52	59.275	<0.001